ESBL-producing organisms: Classification, significance, detection and therapeutic options;ESBL-bildner: Einteilung, signifikanz, diagnostik und therapie

Hygiene + Medizin

Volumn 35, Issue 1-2, 2010, Pages 8-16

  Ditzen, Anette ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Detection; Epidemiology; ESBL; Therapy

Indexed keywords

EID: 77955150761     PISSN: 01723790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Lehner S, Grabein B, Pfaller P, Kopp R. Relevance of ESBL-producing pathogens for clinical surgery. Diagnostics, therapy and prevention. Chirurg 2009;80:27-36.
2. Ambler RP. The structure of ß-lactamases. Philos Trans R Soc Lond B Biol Sci 1980;289:321-31.
3. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for ß-lactamases and its correlation with molecular structure. Antimicrob Agents Chemothar 1995;39:1211-33.
4. Harada S, Ishii Y, Yamaguchi K. Extended-spectrum ß-lactamases: Implications for the Clinical Laboratory and Therapy. Korean J Lab Med 2008;28:401-12.
5. Livermore DM, Paterson DL. Pocket Guide to Extended Spectrum ß-Lactamases in Resistance. London, UK: Current Medicine Group 2006;16.
6. Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother 2001;48(S1):87-102.
7. Jacoby GA, Munoz-Price LS. The new ß-lactamases. N Engl J Med 2005;352:380-391.
8. Deshpande LM, Jones RN, Fritsche TR, Sader HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb Drug Resist 2006;12:223-230. (Pubitemid 46110652)
9. Queenam AM, Bush K. Carbapenemases: the versatile ß-lactamases. Clin Microbiol Rev 2007;20:440-58.
10. Livermore DM. Defining an extended-spectrum ß-lactamase. Clin Microbiol Infect 2008;14(S1):3-10.
11. Jacoby G, Bush K: Lahey clinic page on amino acid sequence for TEM, SHV and OXA extended-sprectrum and inhibitor resistant ß-Lactamases. http://www.lahey.org/Studies/
12. Datta N, Kontomichalou P. Penicillinase synthesis controlles by infectious R factors in Enterobacteriaceae. Nature 1965;208:239-41.
13. Cantón R, Morosini MI, de la Maza OM, de la Pedrosa EG. IRT and CMT ß-lactamases and inhibitor resistance. Clin Microbiol Infect 2008;14(S):S53-62.
14. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315-7. (Pubitemid 14213754)
15. Prinarakis EE, Miriagou V, Tzelepi E, Gazouli M, Tzouvelekis LS. Emergence of an inhibitor-resistant ß-lactamase (SHV-10) derived from an SHV-5 variant. Antimicrob Agents Chemother 1997;41:838-40. (Pubitemid 27150542)
16. Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 1990;18:294-8. (Pubitemid 20349311)
17. Chen Y, Delmas J, Sirot J, Shoichet B, Bonnet R. Atomic resolution structures of CTX-M ß-lactamases: extended spectrum activities from increased mobility and decreased stability. J Mol Biol 2005;348:349-62. (Pubitemid 40462101)
18. Sirot D, Sirot J, Labia R et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel ß-lactamase. J Antimicrob Chemother 1987;20:323-34. (Pubitemid 17140419)
19. Pitout JD, Hanson ND, Church DL, Laupland KB. Population-based laboratory surveillance for Escherichia coli-producing extended spectrum ß-lactamases: importance of community isolates with blaCTX-M genes. Clin Inf Dis 2004;38:1736-41. (Pubitemid 38781666)
20. Rodriguez-Bano J, Navarro MD, Romero L et al. Bacterimia due to extended-spectrum ß-lactamase producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Inf Dis 2006;43:1407-14. (Pubitemid 44845640)
21. Ben-Ami R, Schwaber MJ, Navon-Venezia S et al. Influx of extended-spectrum ß-lactamase producing Enterobacteriaceae into the hospital. Clin Inf Dis 2006;42:925-34.
22. Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA. PEG Resistenzstudie 2007. http://www.p-e-g.org/ag-resistenz/main. htm
23. European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2007. Bilthoven: National Institute of Public Health and the Environment, October 2008. http://www.rivm.nl/earss/result/
24. Goosens H, Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum ß-lactamase-and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). Diagn Microbiol Inf Dis 2005;5:257-64. (Pubitemid 41796896)
25. Chow JW, Satishchandran V, Snyder TA, Harvey CM, Friedland IR, Dinubile MJ. In vitro susceptibilities of aerobic and facultatively anaerobic gramnegative bacilli isolated from patients with intraabdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) 2005;6:439-48.
26. Rossi F, Baquero F, Hsueh PR et al. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006;58:205-10. (Pubitemid 44295010)
27. Geiss HK, Mack D, Seifert H. der Mikrobiologe. 2003;6:222-239
28. Paterson DL, Bonomo RA. Extended-Spectrum ß-Lactamases: a Clinical Update. Clin Microbiol Rev 2005;18(4):657-86.
29. Snyder JW, Munier GK, Johnson CL. Direct Comparison of the BD Phoenix System with the MicroScan WalkAway System for Identification and Antimicrobial Susceptibility Testing of Enterobacteriaceae and Nonfermentative Gram-Negative Organisms. J Clin Microbiol 2008;46(7):2327-33.
30. Fisher MA, Stamper PD, Hujer KM et al. Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum ß-lactamase, AmpC and KPC producers. J Med Microbiol 2009;58:774-8.
31. Färber J, Moder KA, Layer F, Tammer I, König W, König B. Extended-spectrum ß-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium. J Clin Microbiol 2008;46(11):3721-7.
32. Wiegand I, Geiss HK, Mack D, Stürenburg F, Seifert H. Detection of etended-spectrum ß-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol 2005;45:1167-74. (Pubitemid 46626480)
33. Sanguinetti E, Posteraaro B, Spanu T et al. Characterisation of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum ß-lactamase detection method. J Clin Microbiol 2003;41:1463-8. (Pubitemid 36428090)
34. Cohen Stuart J, Mevius D, Al Naiemi N et al. A novel DNA micro-array system for rapid detection of TEM, SHV and CTX-M extended-spectrum betalactamases in Enterobacteriaceae. Vortrag und Abstract O50, ECCMID 2009, Helsinki.
35. Pitout JD, Nordmann P, Laupland KB, et al. Emergence of Enterobacteriaceae producing extendedspectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-59. (Pubitemid 41418336)
36. Thomson KS, Moland ES. Cefepime, piperacillintazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2001;45:3548-54. (Pubitemid 33107876)
37. Rodriguez-Bano J, Navarro MD. Extended-spectrum ß-lactamases in ambulatory care: a clinical perspective. Clin Microbiol Infect 2008;13(S1):104-110 (Pubitemid 350284181)
38. Garau J. Other antimicrobials of interest in the era of extended-spectrum ß-lactamases: fosfomycin, nitrofurantoin and tigecyclin. Clin Microbiol Infect 2008;14(S1):198-202. (Pubitemid 350269204)
39. Pankey GA, Ashcraft DS. In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay. Diagn Microbiol Inf 2009;64:300-4.
40. Falagas ME, Karageogopoulos DE. Extended-spectrum ß-lactamase- producing organisms. J Hosp Inf 2009;73:345-54.